British Columbia Cancer Agency POLICY
1. Patients with Implanted Venous Access Devices (IVADs) placed deep within subcutaneous tissue may need to have their IVAD accessed with longer needles to avoid needle dislodgement and risk of
Download British Columbia Cancer Agency POLICY
Information
Domain:
Source:
Link to this page:
Documents from same domain
Oncology Nutrition High Protein High Energy …
www.bccancer.bc.caHigh Protein High Energy Food Choices 3 Examples of High Protein Foods • All meat (eg. beef, pork, goat, lamb) • Fish and shellfish • All poultry (eg. chicken, turkey, duck)
BC CANCER HAZARDOUS DRUG LIST
www.bccancer.bc.caBC CANCER HAZARDOUS DRUG LIST (Refer to: Pharmacy Directive VI-80 Hazardous Drug List) The BC Cancer Hazardous Drug List (BC Cancer HD List) is comprised of:
Safe Handling of Hazardous Drugs - BC Cancer
www.bccancer.bc.caA.1 Potential Hazards of Handling Hazardous Drugs..... 1 A.2 Hazardous Drug List.....
“Magic” mouthwash explained - BC Cancer
www.bccancer.bc.caFAMILY PRACTICE ONCOLOGY NETWORK JOURNAL / FALL 2014 3 “Magic” mouthwash explained By Dr. Allan Hovan, Provincial Professional Practice Leader,
Symptom Management Guidelines: ORAL …
www.bccancer.bc.caSymptom Management Guidelines: ORAL MUCOSITIS . Definition Oral Mucositis (Stomatitis): An acute inflammation and/or ulceration of the …
Guidelines for Management of CID - BC Cancer
www.bccancer.bc.caDisclaimer Both the format and content of the guidelines will change as they are reviewed and revised on a periodic basis. Any physician using these guidelines to provide
Symptom Management Guidelines: FEVER AND …
www.bccancer.bc.caSymptom Management Guidelines: FEVER AND NEUTROPENIA . Definition • Fever: A single oral temperature of ≥ 38.3° C (101° F) OR a temperature ≥ 38 ° C (100.4 ° F) which lasts more than 1h
Symptom Management Guidelines: XEROSTOMIA
www.bccancer.bc.caSymptom Management Guidelines: XEROSTOMIA. Definition(s) • Xerostomia: abnormal dryness in the mouth characterized by a marked decrease and/or thickening of saliva, may be
Linking the BC Psychosocial Community Oncology …
www.bccancer.bc.caCarolyn Jacob - New Regional Professional Practice Leader at the Centre for the North. We welcome Carolyn Jacob, MSW, RSW to her new role at the BC
DRUG NAME: Crizotinib - BC Cancer
www.bccancer.bc.caCrizotinib BC Cancer Agency Cancer Drug Manual© Page 2 of 6 Crizotinib Developed: 1 April 2014 Revised: 1 September 2014. Caution: • vision disorders. have been reported; ability to drive or operate machinery may be compromised.
Related documents
Registered Nurse The Role of the Oncology
ambulatorynurse.vc.ons.orgThe Role of the Oncology Registered Nurse In Outpatient Medical Oncology Acknowledgements “The Role of the Oncology Registered Nurse in Outpatient Medical Oncology” would not have been possible without the input and expertise provided by Eric Berger,
Coding Central Venous Access Devices
campus.ahima.orgCoding Central Venous Access Devices AHIMA 2008 Audio Seminar Series 1 Notes/Comments/Questions Objectives of this Seminar: Review clinical indications and techniques used to insert a central
Clinical Pharmacy Guide: Chemotherapy Assessment and ...
www.bccancer.bc.caClinical Pharmacy Guide: Chemotherapy Assessment and Review 4th Edition Parenteral Drug Delivery Activated: September 2014 Revision Date: October 5, 2017
PERIPHERALLY INSERTED CENTRAL CATHETER (PICC) …
www.nygh.on.ca4 INTRODUCTION Peripherally Inserted Central Catheters (PICC) are catheters that are peripherally placed (i.e. the arm) but they are considered a central catheter because the catheter tip sits in the central circulation (i.e.
GUIDELINE FOR CLINICAL STAFF ON THE CARE OF : …
www.olchc.ieGUIDELINE FOR CLINICAL STAFF ON THE CARE OF : IMPLANTABLE PORTS Version Number V2 Date of Issue December 2016 Reference Number CVADIP-11-2016-V1 Review Interval 3 yearly Approved By Name: Fionnuala O’Neill Title: Nurse Practice Coordinator
Intraluminal Volume Dose Alteplase for the Clearance of ...
www.thomasland.comHospital Pharmacy 203 Intraluminal Alteplase for Occluded PICC Lines Alteplase, also known as tissue plasminogen activator (tPA), is a fibrinolytic agent indicated for